Feverall Adults
Acetaminophen
Taro Pharmaceuticals U.s.a. Inc.
Human Otc Drug
NDC 51672-2117Feverall Adults also known as Acetaminophen is a human otc drug labeled by 'Taro Pharmaceuticals U.s.a. Inc.'. National Drug Code (NDC) number for Feverall Adults is 51672-2117. This drug is available in dosage form of Suppository. The names of the active, medicinal ingredients in Feverall Adults drug includes Acetaminophen - 650 mg/1 . The currest status of Feverall Adults drug is Active.
Drug Information:
| Drug NDC: | 51672-2117 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Feverall Adults |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Proprietary Name Base: | Feverall |
| The base of the Brand/Proprietary name excluding its suffix. |
| Proprietary Name Suffix: | Adults |
| A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Acetaminophen |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Taro Pharmaceuticals U.s.a. Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Suppository |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ACETAMINOPHEN - 650 mg/1
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | RECTAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | NDA |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 12 Dec, 2013 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 07 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | NDA018337 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Taro Pharmaceuticals U.S.A. Inc.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 198443
209364
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 362O9ITL9D
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 51672-2117-4 | 50 BLISTER PACK in 1 CARTON (51672-2117-4) / 1 SUPPOSITORY in 1 BLISTER PACK (51672-2117-0) | 12 Dec, 2013 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purposes pain reliever/fever reducer
Product Elements:
Feverall adults acetaminophen acetaminophen acetaminophen glyceryl monostearate hydrogenated palm kernel oil peg-100 stearate polysorbate 80
Indications and Usage:
Uses temporarily reduces fever relieves minor aches, pains, and headache
Warnings:
Warnings liver warning this product contains acetaminophen. severe liver damage may occur if an adult or child 12 years and older takes more than 6 doses in 24 hours, which is the maximum daily amount taken with other drugs containing acetaminophen an adult takes 3 or more alcoholic drinks every day while using this product allergy alert: acetaminophen may cause severe skin reactions. symptoms may include: skin reddening blisters rash if a skin reaction occurs, stop use and seek medical help right away. for rectal use only. do not use in children under 12 years. if you are allergic to acetaminophen. with any other drug containing acetaminophen (prescription or nonprescription). if you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. ask a doctor before use if you have liver disease. you are taking the blood thinning drug warfarin. stop use and ask a doctor if fever lasts more than 3 days (72 hours), or recurs. pain gets worse or lasts more than 10 days. n
Read more...ew symptoms occur. redness or swelling is present in the painful area. these may be signs of a serious condition. if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. if swallowed or in case of overdose, get medical help or contact a poison control center right away. quick medical attention is critical in case of overdose for adults and for children even if you do not notice any signs or symptoms.
Do Not Use:
Warnings liver warning this product contains acetaminophen. severe liver damage may occur if an adult or child 12 years and older takes more than 6 doses in 24 hours, which is the maximum daily amount taken with other drugs containing acetaminophen an adult takes 3 or more alcoholic drinks every day while using this product allergy alert: acetaminophen may cause severe skin reactions. symptoms may include: skin reddening blisters rash if a skin reaction occurs, stop use and seek medical help right away. for rectal use only. do not use in children under 12 years. if you are allergic to acetaminophen. with any other drug containing acetaminophen (prescription or nonprescription). if you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. ask a doctor before use if you have liver disease. you are taking the blood thinning drug warfarin. stop use and ask a doctor if fever lasts more than 3 days (72 hours), or recurs. pain gets worse or lasts more than 10 days. new symptoms occur. redness or swelling is present in the painful area. these may be signs of a serious condition. if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. if swallowed or in case of overdose, get medical help or contact a poison control center right away. quick medical attention is critical in case of overdose for adults and for children even if you do not notice any signs or symptoms.
Dosage and Administration:
Directions do not use more than directed remove wrapper carefully insert suppository well up into the rectum adults and children 12 years and older: 1 suppository every 4 to 6 hours while symptoms last do not exceed 6 suppositories in any 24-hour period children under 12 years: ask a doctor
Stop Use:
If a skin reaction occurs, stop use and seek medical help right away. for rectal use only.
Stop use and ask a doctor if fever lasts more than 3 days (72 hours), or recurs. pain gets worse or lasts more than 10 days. new symptoms occur. redness or swelling is present in the painful area. these may be signs of a serious condition.
Package Label Principal Display Panel:
Principal display panel - 50 suppository carton adults' ages 12 years & older feverall ® acetaminophen suppositories pain reliever/fever reducer not for retail sale ndc 51672-2117-4 rectal suppository* *actual size doctor recommended 50 rectal suppositories 650 mg each principal display panel - 50 suppository carton
Further Questions:
Questions? call 1-866-923-4914